Read the small print
What in an offer needs a closer look?
Check the claim that matters, even when the page looks polished.
FDA—the Food and Drug Administration—handles US reviews of medicines.
- A badge on a page
As of 26 September 2026, FDA guidance says that recording a business or a medicine on its register does not mean the FDA has approved either one.
- A claim to check
Ask exactly what was approved, by whom, and where the record can be read.
A badge saying “FDA registered” or “FDA listed” refers to those records. Ask to see the separate record of medicine approval.
When “research use” is offered as an answer
In enforcement letters reviewed on 26 September 2026, the FDA treated research-labeled products promoted for human use as unapproved drugs despite their labels.
Those letters set out allegations about particular businesses, rather than court findings.
Show the doctor the label and the advert. Ask: “The label says research use, but the advert offers treatment. What evidence supports using it for my problem, and which law allows you to supply it to me?”
When the pharmacy stays unnamed
With online orders for compounded medicine, people may not know the pharmacy or other business that prepared it, the FDA notes.
Ask for the full name of the business that would make and supply the proposed medicine. Then use the state pharmacy-board record, rather than a logo, to check the name.
Open FDA’s pharmacy license linksWhen the page promises approval or certainty
A medicine made to order is described as compounded, whether prepared by a pharmacist or a doctor. They are not FDA-approved, according to FDA information reviewed on 26 September 2026.
A claim that BPC-157 has no side effects outruns the limited human safety evidence checked on 28 September 2026.
Ask for the missing record or explanation. Leave the decision open while the answer is unclear.